Cargando…

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

Neuronal surface autoantibodies (NSAbs) against various antigens cause autoimmune encephalitis. Some of these antigens are also involved in the pathology of depression and anxiety. To study whether NSAbs are more common in plasma of individuals with depression and anxiety than in controls, and to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Shenghua, Correia-Hoffmann, Carolin, Mané-Damas, Marina, Kappelmann, Nils, Molenaar, Peter C., van Grootheest, Gerard, Penninx, Brenda W. J. H., Rouhl, Rob P. W., Losen, Mario, Martinez-Martinez, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683539/ https://www.ncbi.nlm.nih.gov/pubmed/33230123 http://dx.doi.org/10.1038/s41398-020-01083-y

Ejemplares similares

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?
por: Zong, Shenghua, et al.
Publicado: (2017)

Unidentified Neuronal Surface IgG Autoantibodies in a Case of Hashimoto's Encephalopathy
por: Mané-Damas, Marina, et al.
Publicado: (2020)

Addendum: Hoffmann, C.; et al. Autoantibodies in Neuropsychiatric Disorders. Antibodies 2016, 5, 9
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1
por: Zong, Shenghua, et al.
Publicado: (2023)

Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report
por: Vinke, Anita M., et al.
Publicado: (2022)

Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
por: Takata, Kazushiro, et al.
Publicado: (2019)

Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
por: Fichtner, Miriam L., et al.
Publicado: (2022)

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders
por: Martinez-Martinez, Pilar, et al.
Publicado: (2013)

Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

Correction: Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
por: Koneczny, Inga, et al.
Publicado: (2022)

Biomarker-based subtyping of depression and anxiety disorders using Latent Class Analysis. A NESDA study
por: Beijers, Lian, et al.
Publicado: (2019)

Toxoplasma gondii seropositivity in patients with depressive and anxiety disorders
por: de Bles, Nienke J., et al.
Publicado: (2020)

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
por: Losen, Mario, et al.
Publicado: (2017)

Differential gene expression patterns between smokers and non‐smokers: cause or consequence?
por: Vink, Jacqueline M., et al.
Publicado: (2015)

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
por: Losen, Mario, et al.
Publicado: (2015)

Toxoplasma gondii seropositivity in patients with depressive and anxiety disorders
por: Bles, N. De, et al.
Publicado: (2021)

Prevention of depression through nutritional strategies in high-risk persons: rationale and design of the MooDFOOD prevention trial
por: Roca, Miquel, et al.
Publicado: (2016)

Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer’s Disease and Control Mice
por: den Hoedt, Sandra, et al.
Publicado: (2021)

Experiential Avoidance and Bordering Psychological Constructs as Predictors of the Onset, Relapse and Maintenance of Anxiety Disorders: One or Many?
por: Spinhoven, Philip, et al.
Publicado: (2017)

The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene
por: Tollenaar, Marieke S., et al.
Publicado: (2017)

Seasonality in depressive and anxiety symptoms among primary care patients and in patients with depressive and anxiety disorders; results from the Netherlands Study of Depression and Anxiety
por: Winthorst, Wim H, et al.
Publicado: (2011)

BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE
por: Hiles, Sarah A., et al.
Publicado: (2016)

Association of food groups with depression and anxiety disorders
por: Gibson-Smith, Deborah, et al.
Publicado: (2019)

Acceptability and feasibility of two interventions in the MooDFOOD Trial: a food-related depression prevention randomised controlled trial in overweight adults with subsyndromal symptoms of depression
por: Owens, Matthew, et al.
Publicado: (2020)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Association Between Depression, Anxiety, and Antidepressant Use With T-Wave Amplitude and QT-Interval
por: Hu, Mandy X., et al.
Publicado: (2018)

Role of inflammation in depression and anxiety: Tests for disorder specificity, linearity and potential causality of association in the UK Biobank
por: Ye, Zheng, et al.
Publicado: (2021)

The predictive value of Approach and Avoidance tendencies on the onset and course of depression and anxiety disorders
por: Struijs, Sascha Y., et al.
Publicado: (2018)

Temporal relationships between happiness and psychiatric disorders and their symptom severity in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA)
por: Spinhoven, Philip, et al.
Publicado: (2021)

Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders
por: Gerrits, Marloes MJG, et al.
Publicado: (2014)

Anxiety sensitivity, its stability and longitudinal association with severity of anxiety symptoms
por: Hovenkamp-Hermelink, Johanna H. M., et al.
Publicado: (2019)

Long-term disability in anxiety disorders
por: Hendriks, Sanne M., et al.
Publicado: (2016)

My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety
por: Johnson, Suzanne Bennett, et al.
Publicado: (2017)

Most Antidepressant Use in Primary Care Is Justified; Results of the Netherlands Study of Depression and Anxiety
por: Piek, Ellen, et al.
Publicado: (2011)

Not urbanization level but socioeconomic, physical and social neighbourhood characteristics are associated with presence and severity of depressive and anxiety disorders
por: Generaal, Ellen, et al.
Publicado: (2019)

Is the beck anxiety inventory a good tool to assess the severity of anxiety? A primary care study in The Netherlands study of depression and anxiety (NESDA)
por: Muntingh, Anna DT, et al.
Publicado: (2011)

Cytokine production capacity in depression and anxiety
por: Vogelzangs, N, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0drmi8lhqoo4114iqtk60bgqm8